December 15, 2024 06:53 (IST)
DCGI approves psoriasis injection Itolizumab to treat COVID patients
Jul 11, 2020, at 06:23 pm
New Delhi/IBNS: The Drugs Controller General of India (DCGI) has approved the psoriasis injection Itolizumab, a drug used to cure skin ailment psoriasis, an auto-immune disorder, for "restricted emergency use" to treat COVID-19 patients having moderate to severe acute respiratory distress, media reports said.
Latest Headlines
DCGI approves psoriasis injection Itolizumab to treat COVID patients
Sat, Jul 11 2020